The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for crisantaspase (Jazz Pharmaceuticals ANZ Pty Ltd)
Active ingredients
crisantaspase
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
JZP-458 is used in combination with other chemotherapeutic agents to treat patients with acute lymphoblastic leukaemia (ALL) or lymphoblastic lymphoma (LBL)
Therapeutic area
Haematology